What to check when consulting on stem-cell and regenerative procedures in Cheongdam · Apgujeong

When you research regenerative procedures around Cheongdam · Apgujeong

Around Cheongdam and Apgujeong, many clinics describe regenerative or autologous-line procedures, and even a short tour can leave the explanations sounding different from one place to the next. Some say "stem cell," others say "SVF" or "autologous cells," and it is hard to tell whether they are renaming the same thing or describing entirely different procedures.

So this article is ordered not as a hospital-shopping checklist, but as a sequence for making terminology concrete. When you ask by source material and processing steps rather than by brand-like names, the reason explanations diverge usually becomes clear. Cellinique Clinic on Dosan-daero — about a 10-minute walk from Apgujeong Station — put the items we actually confirm in consultation into the same order here.

3-line summary

1. "Regenerative," "autologous," and "stem cell" are categories, not a single procedure name. Whether the source material is fat, blood, or human dermis changes preparation, recovery, and what you must confirm.
2. Energy-based lifting (ultrasound · radiofrequency) and injectable regenerative procedures have different kinds of evidence, so ask about them separately. Bundling them into one conversation easily misaligns expectations.
3. What you should leave with from consultation is three things: exact product or material name, treatment area and volume, and criteria for contacting the clinic if something feels wrong. Once those three appear in writing, everything else becomes comparable.

1. Start by narrowing what "stem cell procedure" covers

In everyday language, the category people call a "stem cell procedure" packs together approaches that are not the same in nature. The first job in consultation is to fix which of those approaches is under discussion right now.

What you meet most often is SVF. It is a fraction obtained by processing adipose tissue, and it contains not only adipose-derived stem cells but also endothelial cells, pericytes, immune cells, and more. Unlike the impression the single word "stem cell" can give, the important point is that SVF is a mixture, not a single cell type.

Fact check — evidence level: international society joint statement

In a 2013 joint statement, the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) defined SVF and adipose-derived stromal/stem cells (ASC) as distinct entities and recommended separate nomenclature. SVF is a heterogeneous cell population obtained from adipose tissue; ASC are the adherent cells cultured and selected from that population.
So if an explanation uses one word — "stem cell" — for both, ask which one is meant. (Source: Bourin et al., IFATS · ISCT joint statement)

In short, the first questions in consultation look like this: What is the source material (fat · blood · human dermis)? Is there a culture step? And for which area and purpose will that material be used? Once those three are fixed, later explanations become comparable. How each material changes the consultation is covered further in our PRF · SVF source-material guide.

2. Preparation and recovery split by source material

Even within the same "autologous" family, the same-day process and recovery plan change substantially depending on what you start from. That is why Cellinique Clinic explains these lines separately rather than bundling them.

Starting material	Representative approach	What changes in preparation · recovery
Your own fat	SVF	Includes a fat-harvest step, so the donor site also needs recovery time. Prior health evaluation is required
Your own autologous cells	NovaStem	Schedule is set by the extraction and application method used
Your own blood	PRF	Starts with a blood draw — no donor-site recovery item
Human dermis (hADM)	Re2O · DermaCell	Not autologous tissue, so verifying source and labeling information is central

The cell people most often miss in this table is SVF's donor-site recovery. If you plan only around the treatment area, the calendar can run differently than expected. How to look at the two sites separately is summarized in our SVF recovery guide.

3. Confirm injectable materials by information, not by name

Product names differ even inside the same ingredient family, and the same nickname can point to different compositions over time. So it is more reliable to take the following four items in writing instead of relying on a name alone.

Exact product name and manufacturing · supply information, source material and main ingredients, intended use as written in authorization or use materials, and the areas and volumes planned for this visit. Check that the four do not contradict one another. Especially if the verbal explanation is A while the document's intended use is B, ask on the spot.

Fact check — evidence level: regulatory guidance document

In its dermal-filler guidance, the U.S. FDA explains that if the skin has active inflammation or infection, injection should be deferred until that condition is controlled. It also describes abnormal pain during or right after the procedure, vision changes, and skin around the injection site looking white, gray, or blue-ish as signals that need immediate medical help.
These criteria apply to fillers under the U.S. FDA framework. For other injectable materials, confirm each product's own materials individually. (Source: FDA, dermal fillers)

4. Ask about energy-based and regenerative procedures separately

In consultations around Cheongdam · Apgujeong, lifting and regenerative procedures are often discussed in the same sitting. Asking about both with the same yardstick easily misaligns expectations, because the nature of the evidence differs.

Fact check — evidence level: systematic review

Facial skin-tightening effects of microfocused ultrasound (HIFU), and the efficacy and safety of radiofrequency (RF) for face and neck rejuvenation, are each areas examined in systematic reviews. In other words, energy-based approaches have parts that can be discussed with accumulated literature.
Literature addresses group-level tendencies; individual results still vary with device, settings, and skin condition — three conditions. (Sources: PubMed 36674277, 34923652)

By contrast, autologous regenerative lines differ by institution in source material and processing method, so it is hard to transplant literature under the same name as-is. That is why you should ask for energy-based procedures, "which device and which settings," and for regenerative procedures, "which material and how it is processed," as separate questions.

5. Processing method changes how the system treats the procedure

Even with the same material, how it is processed can change the range in which something is handled as a "procedure." This point is rarely mentioned in consultation, but it is a practical criterion that separates vague explanations from clear ones.

Ways of obtaining cells from fat largely split into methods that digest tissue with enzymes and methods that separate with mechanical force. As processing intensity rises, it becomes harder to view the tissue as only "minimally manipulated," and crossing that boundary moves the work out of simple procedure framing into a separate oversight pathway.

Fact check — evidence level: overseas regulatory policy document

In its regenerative-medicine policy framework, the U.S. FDA treats adipose-derived cells obtained by enzymatic digestion as beyond the scope of "minimal manipulation" and subjects them to a separate authorization pathway. Non-enzymatic, mechanical separation may fall inside the minimal-manipulation range — the distinction is drawn that way.
This distinction applies to the U.S. system. In Korea, a separate framework under the Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products applies, so confirm the actual criteria with the relevant institution directly. (Source: FDA, Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use)

So the three things to ask in consultation are: How is separation performed? Which domestic process does that pathway follow? And can you see the related documents? The difference between a place that answers specifically and a place that moves on with "it is safe" does not show up on a price list, but in practice it is often the largest gap.

Item to confirm	Concrete question to ask	Form to take home
Separation method	Is it enzymatic or mechanical?	Verbal explanation + processing-overview handout
Regulatory process	Which domestic process does this procedure follow?	Written guidance from the relevant institution
Materials used	Exact material name and volume processed per session?	Items stated on the consent form
Responsible clinician	Do the same person cover consultation, procedure, and aftercare?	Confirm during consultation

6. Bring prior procedure history in chronological order

Procedures you have already received are judgment material for the current consultation. Do not rely on memory alone — write them down before the visit.

What to write: what (product · device name), when (even month-level is fine), which area, and how the response went afterward. Especially if you have had injectables or inserts such as fillers or threads, share type and timing. Note the timing of energy-based lifting as well; it helps when a plan is built.

Also prepare a list of medications and health-functional foods you are taking. Do not stop or change doses on your own; the safe order is to share the list first, then discuss with the prescribing clinician.

7. For combined plans, confirm by area

When several procedures sit in one plan, do not look only at total cost and total calendar — confirm by area. Responses can differ by site, and recovery windows need to be staggered so they do not collide.

Concretely: which area gets what first, how many days of buffer each area needs, how the rest of the plan is adjusted if one area reacts differently than expected, and who makes that judgment.

8. Get post-procedure contact criteria in writing

The item that most often drops out of consultation is the contact path when something feels wrong. What happens after the procedure often matters more than the procedure itself, yet this part usually passes only verbally.

Take home three things: which changes warrant contact, where to call, and what to do outside clinic hours. Common observation items are summarized on our procedure safety page, so reading them before consultation helps your questions become specific.

When you receive contact criteria, it helps to split them by time axis. Separate what to check on the day of the procedure, what to watch over the next few days, and what still warrants contact if it persists later. Filling those three columns with what you were told quickly shows where the explanation left gaps.

Also keep what you should store: a copy of the consent form, handouts you received, confirmation information for materials used, and aftercare contact details. Later, when you consult elsewhere or need to describe symptoms, these four make the conversation much more accurate.

9. Location and access are part of the plan

Regenerative lines often include follow-up visits in the plan, so travel distance has a real effect. Especially when donor-site care is needed, as with SVF, you may return within a few days.

For reference, Cellinique Clinic is at 228 Dosan-daero, Yeonseung Building, Gangnam-gu, Seoul, about a 10-minute walk from Apgujeong Station and Hakdong Station. It sits in a living area neighboring Cheongdam-dong, so access from the Cheongdam side is not difficult — but the address is Dosan-daero, not Cheongdam. When you compare clinics, confirm both the registered location and the real travel time; that makes follow-up visits easier to plan.

10. Cheongdam · Apgujeong regenerative procedure consultation checklist

□ Did you confirm whether what is under discussion is SVF or an approach that uses cultured cells
□ Is the source material fat, blood, or human dermis
□ Did you receive the exact product · material name and manufacturing · supply information
□ Are the planned area and volume written down
□ If fat harvest is included, did you hear the donor-site recovery plan
□ Did you ask about energy-based and regenerative procedures as separate questions
□ Did you share prior procedure history and your medication list
□ Did you receive contact criteria for problems and an after-hours path in writing
□ Did you put follow-up visit count and travel distance into the plan

Frequently asked questions

Q1. I am looking for a stem cell procedure in Cheongdam — why do clinic names differ so much?

Because "stem cell" is a category, not a single procedure name. SVF obtained from fat, approaches that use autologous cells, blood-based PRF, and human-dermis–derived materials are all grouped under a broad everyday label. Asking about source material and processing method makes the differences visible.

Q2. Does SVF contain only stem cells?

SVF is a mixed fraction that includes adipose-derived stem cells among several cell types. Endothelial cells, pericytes, immune cells, and others are present together. The 2013 international society joint statement also defines SVF and cultured adipose-derived stromal cells (ASC) as two distinct entities.

Q3. Can I discuss lifting and regenerative procedures in the same consultation?

You can discuss them together, but split the questions. For energy-based lifting, ask about device and settings; for regenerative procedures, ask about material and processing. The nature of the evidence differs, so one yardstick misaligns expectations.

Q4. What should I prepare before consultation?

Prior procedure history (product · device name, timing, area, response), a list of medications and health-functional foods you take, and one written sentence for the concern that bothers you most. Do not stop medicines on your own — just bring the list.

Q5. Is Cellinique Clinic in Cheongdam?

No. It is at 228 Dosan-daero, Yeonseung Building, Gangnam-gu, Seoul, about a 10-minute walk from Apgujeong Station and Hakdong Station. Access from neighboring Cheongdam-dong is not hard, but the address is Dosan-daero.

Consultation guide

At Cellinique Clinic, Medical Director Dr. Kim Gun-woo personally covers pre-procedure health evaluation through the procedure and aftercare. Suitability and composition for regenerative · autologous lines vary by individual condition, so they are confirmed in consultation. Detailed procedure pages are available for SVF, NovaStem, and PRF.

This article is general information and does not replace medical care. Diagnosis and plans suited to your condition should be confirmed in consultation.